DRAFT RECOMMENDATIONS-CLINICAL TRIALS

First Page		Document Content
Pharmaceutical sciences New Drug Application Form FDA 483 Federal Food Drug and Cosmetic Act Criticism of the Food and Drug Administration FDA Warning Letter Food and Drug Administration Health Medicine		DRAFT RECOMMENDATIONS-CLINICAL TRIALS Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 61,85 KB Share Document on Facebook

	Morphochem’s Investigational New Drug (IND) application accepted by FDA – Novel antibacterial for IV treatment of CDI ready to move to Phase 2 Munich (Germany), June 22, 2016 — Morphochem, a clinical-stage pharmace DocID: 1uvYN - View Document
	Emergency Use: means the use of a test article on a human subject in a life-threatening situation in DocID: 1riMu - View Document
	United States Government Accountability Office GAO Report to the Ranking Member, Committee on Finance, U.S. Senate DocID: 1riEa - View Document
	Microsoft Word - FINAL 10K2014-Cover Page final to print DocID: 1r76P - View Document
	Clark Transfer, Inc. Owner-Operator Application IMPORTANT NOTICE REGARDING BACKGROUND REPORTS DocID: 1qZGZ - View Document